Clinical Trial Update: Expanded Access for d-MAPPS™ Ophthalmic Solution, in the Treatment of Chronic Ocular Graft-Versus-Host Disease (oGVHD)

View source ↗

Summary

This notice provides expanded access for d-MAPPS ophthalmic solution to treat chronic ocular graft-versus-host disease (oGVHD). Regenerative Ocular Immunobiolog…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Graft-versus-host Disease

Drugs mentioned

• d-MAPPS Ophthalmic Solution

Snippet

Sponsor: Regenerative Ocular Immunobiologics LLC | Conditions: oGVHD | Status: AVAILABLE